Constellation Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CNST and buy or sell other stocks, ETFs, and their options commission-free!

About CNST

Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. 

CEO
Jigar Raythatha, MBA
CEOJigar Raythatha, MBA
Employees
Employees
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2008
Founded2008
Employees
Employees

CNST Key Statistics

Market cap
1.63B
Market cap1.63B
Price-Earnings ratio
-11.21
Price-Earnings ratio-11.21
Dividend yield
Dividend yield
Average volume
657.81K
Average volume657.81K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$39.30
52 Week high$39.30
52 Week low
$17.00
52 Week low$17.00

Stock Snapshot

With a market cap of 1.63B, Constellation Pharmaceuticals(CNST) trades at $33.99. The stock has a price-to-earnings ratio of -11.21.

Constellation Pharmaceuticals(CNST) stock opened on 2026-05-02 at —. The price climbed to — and dipped to —.

Constellation Pharmaceuticals(CNST) shares are trading with a volume of 0, against a daily average of 657.81K.

During the past year, Constellation Pharmaceuticals(CNST) stock moved between $17.00 at its lowest and $39.30 at its peak.

During the past year, Constellation Pharmaceuticals(CNST) stock moved between $17.00 at its lowest and $39.30 at its peak.

People also own

Based on the portfolios of people who own CNST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.